Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
International Journal of Toxicology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Arfsten, D. P.
Right arrow Articles by Bobb, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arfsten, D. P.
Right arrow Articles by Bobb, A. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Articles

Impact of 30-Day Oral Dosing with N-acetyl-L-cysteine on Sprague-Dawley Rat Physiology

Darryl P. Arfsten1
Eric W. Johnson1
Angie R. Thitoff1
Anne E. Jung1
Erin R. Wilfong1
Scott M. Lohrke1
Tim A. Bausman2
Jeffrey S. Eggers3
Andrew J. Bobb1

1 Naval Health Research Center Environmental Health Effects Laboratory, Wright-Patterson Air Force Base, Ohio, USA
2 ManTech Inc., Wright-Patterson Air Force Base, Ohio, USA
3 Air Force Research Laboratory, Brooks Air Force Base, Texas, USA

Correspondence: Address correspondence to Darryl P. Arfsten, PhD, Naval Health Research Center, Environmental Health Effects Laboratory, 2729 R Street, Building 837, Area B, Wright-Patterson AFB OH 45433-7903, USA. E-mail:darryl.arfsten{at}wpafb.af.mil

A number of studies have demonstrated a protective effect associated with N-acetyl-L-cysteine (NAC) against toxic chemical exposure. However, the impact of long-term oral dosing on tissue pathology has not been determined. In this study, the authors assessed the impact of long-term oral NAC administration on organ histopathology and tissue glutathione (GSH) and total glutathione-S-transferase (GST) activity levels in Sprague-Dawley (SD) rats. Groups of 20 SD rats (10 males, 10 females), 8 weeks of age, were dosed daily by oral gavage with deionized H2O (negative controls) or NAC solution at a rate of 600 or 1200 mg/kg/day for 30 days. Animals were euthanized 6 h after treatment on study day 30. There were no significant differences in final body weights or weekly average weight gain between treatment groups. Serum alanine amino-transferase (ALT) activities were significantly elevated (p ≤.05) in NAC-treated animals compared to controls when measured on study day 30. Histopathologic evaluation of the stomach, small intestine, liver, kidneys, spleen, thymus, and lungs revealed no lesions associated with NAC administration. When measured on study day 30, total GST activity for kidney and skin from NAC-treated animals were increased 39% to 131% as compared to controls. Tissue GSH concentrations from NAC-treated animals were increased 24% to 81% as compared with negative controls. Further studies are needed to determine if the observed increase in tissue GSH concentration and GST activity provide a degree of chemoprotection against dermal and systemic chemical toxicants.

Key Words: Glutathione • Glutathione-S-transferase • N-acetyl-L-cysteine • Oral Toxicity • Rats

International Journal of Toxicology, Vol. 23, No. 4, 239-247 (2004)
DOI: 10.1080/10915810490502041


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
W. L. Baker, M. W. Anglade, E. L. Baker, C. M. White, J. Kluger, and C. I. Coleman
Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis
Eur. J. Cardiothorac. Surg., March 1, 2009; 35(3): 521 - 527.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Ozaydin, O. Peker, D. Erdogan, S. Kapan, Y. Turker, E. Varol, F. Ozguner, A. Dogan, and E. Ibrisim
N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study
Eur. Heart J., March 1, 2008; 29(5): 625 - 631.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
K. C. Carter, S. Hutchison, F. L. Henriquez, D. Legare, M. Ouellette, C. W. Roberts, and A. B. Mullen
Resistance of Leishmania donovani to Sodium Stibogluconate Is Related to the Expression of Host and Parasite {gamma}-Glutamylcysteine Synthetase
Antimicrob. Agents Chemother., January 1, 2006; 50(1): 88 - 95.
[Abstract] [Full Text] [PDF]